Nov 30, 2022
12:1
For every share held, investors received 12. The price per share adjusted from $797.50 to $66.46.
The split itself did not change the total investment value.
Regeneron Pharmaceuticals, Inc. (B3:REGN34) operates in the Pharmaceuticals: major industry.
Regeneron Pharmaceuticals, Inc. company overviewRegeneron Pharmaceuticals, Inc.'s most recent stock split was on November 30, 2022. It was a 12-for-1 forward split, so shareholders received 12 shares for every share they held.
Regeneron Pharmaceuticals, Inc. has split its stock once. This history records one forward split, on November 30, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Regeneron Pharmaceuticals, Inc.'s 12-for-1 split on November 30, 2022, every share became 12 shares.
Regeneron Pharmaceuticals, Inc. has not announced a new split in our records. Its most recent split was on November 30, 2022, 3 years ago. Companies announce splits in advance, and any new B3:REGN34 split will appear on this page.